Apyx Medical Corporation (NASDAQ: APYX) stock closed at 2.92 per share at the end of the most recent trading day (a 1.74% change compared to the prior day closing price) with a volume of 54.09K shares and market capitalization of 101.02M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 266 people. Apyx Medical Corporation CEO is Charles D. Goodwin.

The one-year performance of Apyx Medical Corporation stock is -54.66%, while year-to-date (YTD) performance is 24.79%. APYX stock has a five-year performance of -2.34%. Its 52-week range is between 1.31 and 11.155, which gives APYX stock a 52-week price range ratio of 16.35%

Apyx Medical Corporation currently has a PE ratio of -4.60, a price-to-book (PB) ratio of 2.13, a price-to-sale (PS) ratio of 2.66, a price to cashflow ratio of 133.80, a PEG ratio of 2.32, a ROA of -33.97%, a ROC of -39.34% and a ROE of -43.48%. The company’s profit margin is -53.96%, its EBITDA margin is -36.80%, and its revenue ttm is $31.90 Million , which makes it $0.92 revenue per share.

Of the last four earnings reports from Apyx Medical Corporation, there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. Apyx Medical Corporation’s next earnings report date is 11th May 2023.

The consensus rating of Wall Street analysts for Apyx Medical Corporation is Strong Buy (1), with a target price of $4, which is +36.99% compared to the current price. The earnings rating for Apyx Medical Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Apyx Medical Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Apyx Medical Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.17, ATR14 : 0.24, CCI20 : -20.76, Chaikin Money Flow : 0.20, MACD : -0.07, Money Flow Index : 34.43, ROC : -0.68, RSI : 50.66, STOCH (14,3) : 61.11, STOCH RSI : 1.00, UO : 51.86, Williams %R : -38.89), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Apyx Medical Corporation in the last 12-months were: Andrew Makrides (Option Excercise at a value of $76 200), Charles D. Goodwin (Buy at a value of $70 068), Lawrence J. Waldman (Option Excercise at a value of $83 280), Michael Geraghty (Option Excercise at a value of $26 900), Moshe Citronowicz (Option Excercise at a value of $76 200)